Current U.S. Preventive Services Task Force (USPSTF) recommendations state that men ages 55 to 69 should decide for themselves whether to undergo a prostate-specific antigen (PSA) test after discussing the potential benefits and harms with their doctor. ...
Read More
Urinary incontinence is a possible side effect of many cancer treatments. It’s especially problematic for men who’ve had prostate cancer. Although it may seem like a touchy topic, there’s no room for embarrassment or shame if you’re a prostate cancer sur...
Read More
Many people think skin problems go hand-in-hand with radiation treatments for cancer. But that’s not always the case anymore. “Basically, most things we do now don’t impact the skin at all” said Eric M. Horwitz, MD, FABS, FASTRO, Chair of Radiation Oncol...
Read More
A recent Fox Chase Cancer Center study showed that 80 percent of men who have cryoablation surgery for recurrent prostate cancer can safely delay the start of androgen deprivation therapy (ADT) for two or more years and, as a result, avoid the risk of cardi...
Read More
Two Fox Chase Cancer Center urologic oncologists participated in presentations at the spring 2018 annual meeting of the American Urological Association (AUA) and the Society for Urologic Oncology (SUO). Rosalia Viterbo, MD, FACS, brought her extensive ex...
Read More
When it comes to cancer care, looking at a patient’s case from different perspectives is an essential part of deciding the best treatment approach. That’s why tumor boards are so crucial. These meetings provide a huge benefit to patients, though it’s a proc...
Read More
